 | • レポートコード：MRC2-11QY09143 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、154ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はRNAベースバイオ医薬品のグローバル市場について調査・分析したレポートです。種類別（治療薬、ワクチン）市場規模、用途別（がん、糖尿病、結核、循環器疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別RNAベースバイオ医薬品の競争状況、市場シェア ・世界のRNAベースバイオ医薬品市場：種類別市場規模 2015年-2020年（治療薬、ワクチン） ・世界のRNAベースバイオ医薬品市場：種類別市場規模予測 2021年-2026年（治療薬、ワクチン） ・世界のRNAベースバイオ医薬品市場：用途別市場規模 2015年-2020年（がん、糖尿病、結核、循環器疾患、その他） ・世界のRNAベースバイオ医薬品市場：用途別市場規模予測 2021年-2026年（がん、糖尿病、結核、循環器疾患、その他） ・北米のRNAベースバイオ医薬品市場分析：米国、カナダ ・ヨーロッパのRNAベースバイオ医薬品市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのRNAベースバイオ医薬品市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のRNAベースバイオ医薬品市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのRNAベースバイオ医薬品市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Roche、Sanofi-Aventis、Abbott Laboratories、Arrowhead Pharmaceuticals、Benitec Biopharma、Calimmune Inc、Dicerna、Gradalis、Quark、RXi、Senesco、Silence Therapeutics、Silenseed、Tekmira、Alnylam Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global RNA-based Biopharmaceuticals Market
The global RNA-based Biopharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global RNA-based Biopharmaceuticals Scope and Market Size
RNA-based Biopharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global RNA-based Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the RNA-based Biopharmaceuticals market is segmented into
Therapeutics
Vaccines
Segment by Application, the RNA-based Biopharmaceuticals market is segmented into
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Regional and Country-level Analysis
The RNA-based Biopharmaceuticals market is analysed and market size information is provided by regions (countries).
The key regions covered in the RNA-based Biopharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and RNA-based Biopharmaceuticals Market Share Analysis
RNA-based Biopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in RNA-based Biopharmaceuticals business, the date to enter into the RNA-based Biopharmaceuticals market, RNA-based Biopharmaceuticals product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
1 Study Coverage
1.1 RNA-based Biopharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key RNA-based Biopharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global RNA-based Biopharmaceuticals Market Size Growth Rate by Type
1.4.2 Therapeutics
1.4.3 Vaccines
1.5 Market by Application
1.5.1 Global RNA-based Biopharmaceuticals Market Size Growth Rate by Application
1.5.2 Cancer
1.5.3 Diabetes
1.5.4 Tuberculosis
1.5.5 Cardiovascular Diseases
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global RNA-based Biopharmaceuticals Market Size, Estimates and Forecasts
2.1.1 Global RNA-based Biopharmaceuticals Revenue 2015-2026
2.1.2 Global RNA-based Biopharmaceuticals Sales 2015-2026
2.2 Global RNA-based Biopharmaceuticals, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global RNA-based Biopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global RNA-based Biopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global RNA-based Biopharmaceuticals Competitor Landscape by Players
3.1 RNA-based Biopharmaceuticals Sales by Manufacturers
3.1.1 RNA-based Biopharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 RNA-based Biopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.2 RNA-based Biopharmaceuticals Revenue by Manufacturers
3.2.1 RNA-based Biopharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 RNA-based Biopharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global RNA-based Biopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by RNA-based Biopharmaceuticals Revenue in 2019
3.2.5 Global RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 RNA-based Biopharmaceuticals Price by Manufacturers
3.4 RNA-based Biopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 RNA-based Biopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers RNA-based Biopharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into RNA-based Biopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global RNA-based Biopharmaceuticals Market Size by Type (2015-2020)
4.1.1 Global RNA-based Biopharmaceuticals Sales by Type (2015-2020)
4.1.2 Global RNA-based Biopharmaceuticals Revenue by Type (2015-2020)
4.1.3 RNA-based Biopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
4.2 Global RNA-based Biopharmaceuticals Market Size Forecast by Type (2021-2026)
4.2.1 Global RNA-based Biopharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 RNA-based Biopharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global RNA-based Biopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global RNA-based Biopharmaceuticals Market Size by Application (2015-2020)
5.1.1 Global RNA-based Biopharmaceuticals Sales by Application (2015-2020)
5.1.2 Global RNA-based Biopharmaceuticals Revenue by Application (2015-2020)
5.1.3 RNA-based Biopharmaceuticals Price by Application (2015-2020)
5.2 RNA-based Biopharmaceuticals Market Size Forecast by Application (2021-2026)
5.2.1 Global RNA-based Biopharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global RNA-based Biopharmaceuticals Price Forecast by Application (2021-2026)
6 North America
6.1 North America RNA-based Biopharmaceuticals by Country
6.1.1 North America RNA-based Biopharmaceuticals Sales by Country
6.1.2 North America RNA-based Biopharmaceuticals Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America RNA-based Biopharmaceuticals Market Facts & Figures by Type
6.3 North America RNA-based Biopharmaceuticals Market Facts & Figures by Application
7 Europe
7.1 Europe RNA-based Biopharmaceuticals by Country
7.1.1 Europe RNA-based Biopharmaceuticals Sales by Country
7.1.2 Europe RNA-based Biopharmaceuticals Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe RNA-based Biopharmaceuticals Market Facts & Figures by Type
7.3 Europe RNA-based Biopharmaceuticals Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific RNA-based Biopharmaceuticals by Region
8.1.1 Asia Pacific RNA-based Biopharmaceuticals Sales by Region
8.1.2 Asia Pacific RNA-based Biopharmaceuticals Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific RNA-based Biopharmaceuticals Market Facts & Figures by Type
8.3 Asia Pacific RNA-based Biopharmaceuticals Market Facts & Figures by Application
9 Latin America
9.1 Latin America RNA-based Biopharmaceuticals by Country
9.1.1 Latin America RNA-based Biopharmaceuticals Sales by Country
9.1.2 Latin America RNA-based Biopharmaceuticals Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America RNA-based Biopharmaceuticals Market Facts & Figures by Type
9.3 Central & South America RNA-based Biopharmaceuticals Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa RNA-based Biopharmaceuticals by Country
10.1.1 Middle East and Africa RNA-based Biopharmaceuticals Sales by Country
10.1.2 Middle East and Africa RNA-based Biopharmaceuticals Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa RNA-based Biopharmaceuticals Market Facts & Figures by Type
10.3 Middle East and Africa RNA-based Biopharmaceuticals Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer RNA-based Biopharmaceuticals Products Offered
11.1.5 Pfizer Related Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Description and Business Overview
11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Roche RNA-based Biopharmaceuticals Products Offered
11.2.5 Roche Related Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Corporation Information
11.3.2 Sanofi-Aventis Description and Business Overview
11.3.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Products Offered
11.3.5 Sanofi-Aventis Related Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Corporation Information
11.4.2 Abbott Laboratories Description and Business Overview
11.4.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Products Offered
11.4.5 Abbott Laboratories Related Developments
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Corporation Information
11.5.2 Arrowhead Pharmaceuticals Description and Business Overview
11.5.3 Arrowhead Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Products Offered
11.5.5 Arrowhead Pharmaceuticals Related Developments
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Corporation Information
11.6.2 Benitec Biopharma Description and Business Overview
11.6.3 Benitec Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Products Offered
11.6.5 Benitec Biopharma Related Developments
11.7 Calimmune Inc
11.7.1 Calimmune Inc Corporation Information
11.7.2 Calimmune Inc Description and Business Overview
11.7.3 Calimmune Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Calimmune Inc RNA-based Biopharmaceuticals Products Offered
11.7.5 Calimmune Inc Related Developments
11.8 Dicerna
11.8.1 Dicerna Corporation Information
11.8.2 Dicerna Description and Business Overview
11.8.3 Dicerna Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Dicerna RNA-based Biopharmaceuticals Products Offered
11.8.5 Dicerna Related Developments
11.9 Gradalis
11.9.1 Gradalis Corporation Information
11.9.2 Gradalis Description and Business Overview
11.9.3 Gradalis Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Gradalis RNA-based Biopharmaceuticals Products Offered
11.9.5 Gradalis Related Developments
11.10 Quark
11.10.1 Quark Corporation Information
11.10.2 Quark Description and Business Overview
11.10.3 Quark Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Quark RNA-based Biopharmaceuticals Products Offered
11.10.5 Quark Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer RNA-based Biopharmaceuticals Products Offered
11.1.5 Pfizer Related Developments
11.12 Senesco
11.12.1 Senesco Corporation Information
11.12.2 Senesco Description and Business Overview
11.12.3 Senesco Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Senesco Products Offered
11.12.5 Senesco Related Developments
11.13 Silence Therapeutics
11.13.1 Silence Therapeutics Corporation Information
11.13.2 Silence Therapeutics Description and Business Overview
11.13.3 Silence Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Silence Therapeutics Products Offered
11.13.5 Silence Therapeutics Related Developments
11.14 Silenseed
11.14.1 Silenseed Corporation Information
11.14.2 Silenseed Description and Business Overview
11.14.3 Silenseed Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Silenseed Products Offered
11.14.5 Silenseed Related Developments
11.15 Tekmira
11.15.1 Tekmira Corporation Information
11.15.2 Tekmira Description and Business Overview
11.15.3 Tekmira Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Tekmira Products Offered
11.15.5 Tekmira Related Developments
11.16 Alnylam Pharmaceuticals
11.16.1 Alnylam Pharmaceuticals Corporation Information
11.16.2 Alnylam Pharmaceuticals Description and Business Overview
11.16.3 Alnylam Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Alnylam Pharmaceuticals Products Offered
11.16.5 Alnylam Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 RNA-based Biopharmaceuticals Market Estimates and Projections by Region
12.1.1 Global RNA-based Biopharmaceuticals Sales Forecast by Regions 2021-2026
12.1.2 Global RNA-based Biopharmaceuticals Revenue Forecast by Regions 2021-2026
12.2 North America RNA-based Biopharmaceuticals Market Size Forecast (2021-2026)
12.2.1 North America: RNA-based Biopharmaceuticals Sales Forecast (2021-2026)
12.2.2 North America: RNA-based Biopharmaceuticals Revenue Forecast (2021-2026)
12.2.3 North America: RNA-based Biopharmaceuticals Market Size Forecast by Country (2021-2026)
12.3 Europe RNA-based Biopharmaceuticals Market Size Forecast (2021-2026)
12.3.1 Europe: RNA-based Biopharmaceuticals Sales Forecast (2021-2026)
12.3.2 Europe: RNA-based Biopharmaceuticals Revenue Forecast (2021-2026)
12.3.3 Europe: RNA-based Biopharmaceuticals Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific RNA-based Biopharmaceuticals Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: RNA-based Biopharmaceuticals Sales Forecast (2021-2026)
12.4.2 Asia Pacific: RNA-based Biopharmaceuticals Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: RNA-based Biopharmaceuticals Market Size Forecast by Region (2021-2026)
12.5 Latin America RNA-based Biopharmaceuticals Market Size Forecast (2021-2026)
12.5.1 Latin America: RNA-based Biopharmaceuticals Sales Forecast (2021-2026)
12.5.2 Latin America: RNA-based Biopharmaceuticals Revenue Forecast (2021-2026)
12.5.3 Latin America: RNA-based Biopharmaceuticals Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa RNA-based Biopharmaceuticals Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: RNA-based Biopharmaceuticals Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: RNA-based Biopharmaceuticals Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: RNA-based Biopharmaceuticals Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key RNA-based Biopharmaceuticals Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 RNA-based Biopharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. RNA-based Biopharmaceuticals Market Segments
Table 2. Ranking of Global Top RNA-based Biopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global RNA-based Biopharmaceuticals Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Therapeutics
Table 5. Major Manufacturers of Vaccines
Table 6. Global RNA-based Biopharmaceuticals Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global RNA-based Biopharmaceuticals Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global RNA-based Biopharmaceuticals Sales by Regions 2015-2020 (K Units)
Table 9. Global RNA-based Biopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 10. Global RNA-based Biopharmaceuticals Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global RNA-based Biopharmaceuticals Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global RNA-based Biopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 13. Global RNA-based Biopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global RNA-based Biopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA-based Biopharmaceuticals as of 2019)
Table 15. RNA-based Biopharmaceuticals Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. RNA-based Biopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers RNA-based Biopharmaceuticals Price (2015-2020) (USD/Unit)
Table 18. RNA-based Biopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers RNA-based Biopharmaceuticals Product Type
Table 20. Date of International Manufacturers Enter into RNA-based Biopharmaceuticals Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global RNA-based Biopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 23. Global RNA-based Biopharmaceuticals Sales Share by Type (2015-2020)
Table 24. Global RNA-based Biopharmaceuticals Revenue by Type (2015-2020) (US$ Million)
Table 25. Global RNA-based Biopharmaceuticals Revenue Share by Type (2015-2020)
Table 26. RNA-based Biopharmaceuticals Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global RNA-based Biopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 28. Global RNA-based Biopharmaceuticals Sales Share by Application (2015-2020)
Table 29. North America RNA-based Biopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 30. North America RNA-based Biopharmaceuticals Sales Market Share by Country (2015-2020)
Table 31. North America RNA-based Biopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 32. North America RNA-based Biopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 33. North America RNA-based Biopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 34. North America RNA-based Biopharmaceuticals Sales Market Share by Type (2015-2020)
Table 35. North America RNA-based Biopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 36. North America RNA-based Biopharmaceuticals Sales Market Share by Application (2015-2020)
Table 37. Europe RNA-based Biopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 38. Europe RNA-based Biopharmaceuticals Sales Market Share by Country (2015-2020)
Table 39. Europe RNA-based Biopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe RNA-based Biopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 41. Europe RNA-based Biopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 42. Europe RNA-based Biopharmaceuticals Sales Market Share by Type (2015-2020)
Table 43. Europe RNA-based Biopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 44. Europe RNA-based Biopharmaceuticals Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific RNA-based Biopharmaceuticals Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific RNA-based Biopharmaceuticals Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific RNA-based Biopharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific RNA-based Biopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific RNA-based Biopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific RNA-based Biopharmaceuticals Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific RNA-based Biopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific RNA-based Biopharmaceuticals Sales Market Share by Application (2015-2020)
Table 53. Latin America RNA-based Biopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 54. Latin America RNA-based Biopharmaceuticals Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa RNA-based Biopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America RNA-based Biopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 57. Latin America RNA-based Biopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 58. Latin America RNA-based Biopharmaceuticals Sales Market Share by Type (2015-2020)
Table 59. Latin America RNA-based Biopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 60. Latin America RNA-based Biopharmaceuticals Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa RNA-based Biopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa RNA-based Biopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa RNA-based Biopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa RNA-based Biopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa RNA-based Biopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share by Application (2015-2020)
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Major Businesses
Table 71. Pfizer RNA-based Biopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Pfizer Product
Table 73. Pfizer Recent Development
Table 74. Roche Corporation Information
Table 75. Roche Description and Major Businesses
Table 76. Roche RNA-based Biopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Roche Product
Table 78. Roche Recent Development
Table 79. Sanofi-Aventis Corporation Information
Table 80. Sanofi-Aventis Description and Major Businesses
Table 81. Sanofi-Aventis RNA-based Biopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Sanofi-Aventis Product
Table 83. Sanofi-Aventis Recent Development
Table 84. Abbott Laboratories Corporation Information
Table 85. Abbott Laboratories Description and Major Businesses
Table 86. Abbott Laboratories RNA-based Biopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Abbott Laboratories Product
Table 88. Abbott Laboratories Recent Development
Table 89. Arrowhead Pharmaceuticals Corporation Information
Table 90. Arrowhead Pharmaceuticals Description and Major Businesses
Table 91. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Arrowhead Pharmaceuticals Product
Table 93. Arrowhead Pharmaceuticals Recent Development
Table 94. Benitec Biopharma Corporation Information
Table 95. Benitec Biopharma Description and Major Businesses
Table 96. Benitec Biopharma RNA-based Biopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Benitec Biopharma Product
Table 98. Benitec Biopharma Recent Development
Table 99. Calimmune Inc Corporation Information
Table 100. Calimmune Inc Description and Major Businesses
Table 101. Calimmune Inc RNA-based Biopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Calimmune Inc Product
Table 103. Calimmune Inc Recent Development
Table 104. Dicerna Corporation Information
Table 105. Dicerna Description and Major Businesses
Table 106. Dicerna RNA-based Biopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Dicerna Product
Table 108. Dicerna Recent Development
Table 109. Gradalis Corporation Information
Table 110. Gradalis Description and Major Businesses
Table 111. Gradalis RNA-based Biopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Gradalis Product
Table 113. Gradalis Recent Development
Table 114. Quark Corporation Information
Table 115. Quark Description and Major Businesses
Table 116. Quark RNA-based Biopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Quark Product
Table 118. Quark Recent Development
Table 119. RXi Corporation Information
Table 120. RXi Description and Major Businesses
Table 121. RXi RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. RXi Product
Table 123. RXi Recent Development
Table 124. Senesco Corporation Information
Table 125. Senesco Description and Major Businesses
Table 126. Senesco RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Senesco Product
Table 128. Senesco Recent Development
Table 129. Silence Therapeutics Corporation Information
Table 130. Silence Therapeutics Description and Major Businesses
Table 131. Silence Therapeutics RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Silence Therapeutics Product
Table 133. Silence Therapeutics Recent Development
Table 134. Silenseed Corporation Information
Table 135. Silenseed Description and Major Businesses
Table 136. Silenseed RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Silenseed Product
Table 138. Silenseed Recent Development
Table 139. Tekmira Corporation Information
Table 140. Tekmira Description and Major Businesses
Table 141. Tekmira RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Tekmira Product
Table 143. Tekmira Recent Development
Table 144. Alnylam Pharmaceuticals Corporation Information
Table 145. Alnylam Pharmaceuticals Description and Major Businesses
Table 146. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Alnylam Pharmaceuticals Product
Table 148. Alnylam Pharmaceuticals Recent Development
Table 149. Global RNA-based Biopharmaceuticals Sales Forecast by Regions (2021-2026) (K Units)
Table 150. Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Regions (2021-2026)
Table 151. Global RNA-based Biopharmaceuticals Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 152. Global RNA-based Biopharmaceuticals Revenue Market Share Forecast by Regions (2021-2026)
Table 153. North America: RNA-based Biopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 154. North America: RNA-based Biopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 155. Europe: RNA-based Biopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 156. Europe: RNA-based Biopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 157. Asia Pacific: RNA-based Biopharmaceuticals Sales Forecast by Region (2021-2026) (K Units)
Table 158. Asia Pacific: RNA-based Biopharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 159. Latin America: RNA-based Biopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 160. Latin America: RNA-based Biopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 161. Middle East and Africa: RNA-based Biopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 162. Middle East and Africa: RNA-based Biopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 163. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 164. Key Challenges
Table 165. Market Risks
Table 166. Main Points Interviewed from Key RNA-based Biopharmaceuticals Players
Table 167. RNA-based Biopharmaceuticals Customers List
Table 168. RNA-based Biopharmaceuticals Distributors List
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA-based Biopharmaceuticals Product Picture
Figure 2. Global RNA-based Biopharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Therapeutics Product Picture
Figure 4. Vaccines Product Picture
Figure 5. Global RNA-based Biopharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 6. Cancer
Figure 7. Diabetes
Figure 8. Tuberculosis
Figure 9. Cardiovascular Diseases
Figure 10. Others
Figure 11. RNA-based Biopharmaceuticals Report Years Considered
Figure 12. Global RNA-based Biopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 13. Global RNA-based Biopharmaceuticals Sales 2015-2026 (K Units)
Figure 14. Global RNA-based Biopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global RNA-based Biopharmaceuticals Sales Market Share by Region (2015-2020)
Figure 16. Global RNA-based Biopharmaceuticals Sales Market Share by Region in 2019
Figure 17. Global RNA-based Biopharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 18. Global RNA-based Biopharmaceuticals Revenue Market Share by Region in 2019
Figure 19. Global RNA-based Biopharmaceuticals Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by RNA-based Biopharmaceuticals Revenue in 2019
Figure 21. RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global RNA-based Biopharmaceuticals Sales Market Share by Type (2015-2020)
Figure 23. Global RNA-based Biopharmaceuticals Sales Market Share by Type in 2019
Figure 24. Global RNA-based Biopharmaceuticals Revenue Market Share by Type (2015-2020)
Figure 25. Global RNA-based Biopharmaceuticals Revenue Market Share by Type in 2019
Figure 26. Global RNA-based Biopharmaceuticals Market Share by Price Range (2015-2020)
Figure 27. Global RNA-based Biopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 28. Global RNA-based Biopharmaceuticals Sales Market Share by Application in 2019
Figure 29. Global RNA-based Biopharmaceuticals Revenue Market Share by Application (2015-2020)
Figure 30. Global RNA-based Biopharmaceuticals Revenue Market Share by Application in 2019
Figure 31. North America RNA-based Biopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America RNA-based Biopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America RNA-based Biopharmaceuticals Sales Market Share by Country in 2019
Figure 34. North America RNA-based Biopharmaceuticals Revenue Market Share by Country in 2019
Figure 35. U.S. RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America RNA-based Biopharmaceuticals Market Share by Type in 2019
Figure 40. North America RNA-based Biopharmaceuticals Market Share by Application in 2019
Figure 41. Europe RNA-based Biopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe RNA-based Biopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe RNA-based Biopharmaceuticals Sales Market Share by Country in 2019
Figure 44. Europe RNA-based Biopharmaceuticals Revenue Market Share by Country in 2019
Figure 45. Germany RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 48. France RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe RNA-based Biopharmaceuticals Market Share by Type in 2019
Figure 56. Europe RNA-based Biopharmaceuticals Market Share by Application in 2019
Figure 57. Asia Pacific RNA-based Biopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific RNA-based Biopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific RNA-based Biopharmaceuticals Sales Market Share by Region in 2019
Figure 60. Asia Pacific RNA-based Biopharmaceuticals Revenue Market Share by Region in 2019
Figure 61. China RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 62. China RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 68. India RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific RNA-based Biopharmaceuticals Market Share by Type in 2019
Figure 84. Asia Pacific RNA-based Biopharmaceuticals Market Share by Application in 2019
Figure 85. Latin America RNA-based Biopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America RNA-based Biopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America RNA-based Biopharmaceuticals Sales Market Share by Country in 2019
Figure 88. Latin America RNA-based Biopharmaceuticals Revenue Market Share by Country in 2019
Figure 89. Mexico RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America RNA-based Biopharmaceuticals Market Share by Type in 2019
Figure 96. Latin America RNA-based Biopharmaceuticals Market Share by Application in 2019
Figure 97. Middle East and Africa RNA-based Biopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa RNA-based Biopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share by Country in 2019
Figure 100. Middle East and Africa RNA-based Biopharmaceuticals Revenue Market Share by Country in 2019
Figure 101. Turkey RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E RNA-based Biopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E RNA-based Biopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa RNA-based Biopharmaceuticals Market Share by Type in 2019
Figure 108. Middle East and Africa RNA-based Biopharmaceuticals Market Share by Application in 2019
Figure 109. North America RNA-based Biopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America RNA-based Biopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe RNA-based Biopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe RNA-based Biopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific RNA-based Biopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific RNA-based Biopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America RNA-based Biopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America RNA-based Biopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa RNA-based Biopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa RNA-based Biopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
RNAベース治療薬・ワクチンの世界市場（～2026年） RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions. RNA-based biopharmaceuticals are a relatively new …- バイオ医薬品用シングルユース技術の世界市場（～2026年） Market Analysis and Insights: Global Single Use Technologies for Biopharmaceuticals Market The global Single Use Technologies for Biopharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Single Use Technologi…
- ペプチド心血管治療薬の世界市場（～2026年） Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart diseas…
- ペプチド癌治療薬の世界市場（～2026年） Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer. Market Analysis and Insights: Global Peptide Based Cancer Therapeuti…
- 慢性肝疾患治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chronic Liver Diseases Therapeutics Market The global Chronic Liver Diseases Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and hig…